OTX-DED

DRUG2 trials

Sponsors

Ocular Therapeutix, Inc.

Conditions

Dry EyeDry Eye SyndromesEye Diseases

Phase 2

To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease

CompletedNCT04747977

Ocular Therapeutix, Inc.Dry Eye

Start: 2021-02-12End: 2021-09-22Updated: 2023-02-22

OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

CompletedNCT05814757

Ocular Therapeutix, Inc.Dry Eye Syndromes, Eye Diseases

Start: 2023-05-11End: 2024-05-22Updated: 2024-07-10